The oral formulation led to up to 12.2% weight loss over three months, a weaker outcome versus late-stage treatments from Eli Lilly and Novo Nordisk.

We recently published 10 Stocks Hammered Harder Than Wall Street. Viking Therapeutics, Inc. (NASDAQ:VKTX) is one of Tuesday’s worst performers. Viking Therapeutics fell by 42.12 percent on Tuesday to close at $24.

Viking Therapeutics Inc.’s worst stock drop in nine years has handed traders betting against the company a gain big enough to turn their money-losing year into a profitable one.